Non-aqueous polar aprotic peptide formulations

Details Non-aqueous polar aprotic peptide formulations Non-aqueous polar aprotic peptide formulations

1999-04-19

2000-09-26

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 15, 530313, 530328, 424600, A61K 3800, A61K 3824, C07K 500, C07K 700

Patent

active

061242616

ABSTRACT:
This invention relates to stable non-aqueous polar aprotic formulations of peptide compounds. These stable formulations comprise peptide in non-aqueous polar aprotic solvent. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.

REFERENCES:
patent: 3914412 (1975-10-01), Gendrich et al.
patent: 4547370 (1985-10-01), Roeske
patent: 4661472 (1987-04-01), Rivier et al.
patent: 4689396 (1987-08-01), Roeske et al.
patent: 4851385 (1989-07-01), Roeske
patent: 5034229 (1991-07-01), Magruder et al.
patent: 5057318 (1991-10-01), Magruder et al.
patent: 5110596 (1992-05-01), Magruder et al.
patent: 5198533 (1993-03-01), Schally et al.
patent: 5480868 (1996-01-01), Kamei et al.
patent: 5932547 (1999-08-01), Stevenson et al.
Factrel (gonadorelin HCl for subcutaneous or IV injection), Physician's Desk Ref., 50th Ed., pp. 2877-2878 (1996).
Fu Lu, et al., "Percutaneous Absorption Enhancement of Leuprolide", Pharm. Res., 9/12, pp. 1575-1576 (1992).
Helm, et al., "Stability of Gonadorelin and Triptorelin in Aqueous Solution", Pharm. Res., 7/12, pp. 1253-1256 (1990).
Johnson, et al., "Degradation of the LH-RH Analog Nafarelin Acetate in Aqueous Solution", Intl. J. Pharm., 31, pp. 125-129 (1986).
Lupron (leuprolide acetate for subcutaneous injection), Physician's Desk Ref., 50th Ed., pp. 2555-2556 (1996).
Lupron Depot (leuprolide acetate for depot suspension), Physician's Desk Ref., 50th Ed., pp. 2556-2562 (1996).
Lutrepulse (gonadorelin acetate for IV injection), Physician's Desk Ref., 50th Ed., pp. 980-982 (1996).
Okada, et al., "New Degradation Product of Des-Gly.sup.10 -NH.sub.2 -LH-RH-Ethylamide (Fertirelin) in Aqueous Solution", J. Pharm. Sci., 80/2, pp. 167-170 (1991).
Okada, et al., "Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers", Pharm. Res., 11/8, pp. 1143-1147 (1994).
Oyler, et al., "Characterization of the Solution Degradation Products of Histrelin, a Gonadotropin Releasing Hormone (LH/RH) Agonist", J. Pharm. Sci., 80/3, pp. 271-275 (1991).
Powell, et al., "Parenteral Peptide Formulations: Chemical and Physical Properties of Native Luteinizing Hormone-Releasing Hormone (LHRH) and Hydrophobic Analogues in Aqueous Solution", Pharm. Res., 8/10, pp. 1258-1263 (1991).
Powell, et al., "Peptide Liquid Crystals: Inverse Correlation of Kinetic Formation and Thermodynamic Stability in Aqueous Solution", Pharm. Res., 11/9, pp. 1352-1354 (1994).
Powers, et al., "Solution Behavior of Leuprolide Acetate, an LHRH Agonist, as Determined by Circular Dichroism Spectroscopy", Intl. J. Pharm., 108, pp. 49-55 (1994).
Shi, et al., "Long-Term Stability of Aqueous Solutions of Luteinizing Hormone-Releasing Hormone Assessed by an In-Vitro Bioassay and Liquid Chromatography", J. Pharm. Sci., 73/6, pp. 819-821 (1984).
Toguchi, "Pharmaceutical Manipulation of Leuprorelin Acetate to Improve Clinical Performance", J. Intl. Med. Res., 18, pp. 35-41 (1990).
Zoladex (goserelin acetate implant), Physician's Desk Ref., 50th Ed., pp. 2858-2861 (1996).

Affiliated with

Also associated with

Rating

Non-aqueous polar aprotic peptide formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-aqueous polar aprotic peptide formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-aqueous polar aprotic peptide formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2100187